Crustacean Molecular Biology and Genomics Division, Biomaterials and Biotechnology in Animal Health Lab, Department of Animal Health and Management, Alagappa University, Science Block, 6th Floor, Burma Colony, Karaikudi 630 003, Tamil Nadu, India.
Crustacean Molecular Biology and Genomics Division, Biomaterials and Biotechnology in Animal Health Lab, Department of Animal Health and Management, Alagappa University, Science Block, 6th Floor, Burma Colony, Karaikudi 630 003, Tamil Nadu, India.
Microb Pathog. 2018 Jan;114:17-24. doi: 10.1016/j.micpath.2017.11.011. Epub 2017 Nov 11.
The successful treatment of multi-drug resistant microbial pathogens represents a major challenge for public health management. Here, chitosan-alginate (CS/ALG) microspheres with narrow size distribution were fabricated by ionically cross linking method using Ca ions as agents for polymer solidification. The physicochemical properties of CS/ALG microspheres, such as surface morphology and size, were studied by SEM. The functional group interactions were confirmed by Fourier transform infrared (FTIR) spectroscopy. SEM revealed that the CS/ALG microspheres were spherical in shape with smooth surfaces, size was 50-100 μm. The synthesized CS/ALG microspheres showed antibacterial and antibiofilm activity on bacteria of public health relevance. CS/ALG microspheres exhibited antibacterial activity at the concentration of 5-20 μg, with significant inhibitory zones on multiple antibiotic resistant pathogens, including Gram positive Staphylococcus aureus, Enterococcus faecalis, and Gram negative Pseudomonas aeruginosa and Proteus vulgaris. Furthermore, in situ light microscopy and confocal laser scanning microscopy (CLSM) showed that CS/ALG microspheres inhibited the bacterial biofilm formation in S. aureus, E. faecalis P. aeruginosa and P. vulgaris after a single treatment with 40 μg. Overall, our findings underlined that chemically synthesized CS/ALG biomaterial has high antibacterial and antibiofilm activity against a number of microbial pathogens of interest for human health, thus this synthesis route can be further exploited for drug development in current biomedical science.
成功治疗多药耐药的微生物病原体是公共卫生管理的主要挑战。在这里,通过离子交联法使用 Ca 离子作为聚合物固化剂制备具有窄粒径分布的壳聚糖-海藻酸钠(CS/ALG)微球。通过 SEM 研究 CS/ALG 微球的物理化学性质,如表面形态和粒径。通过傅里叶变换红外(FTIR)光谱确认官能团相互作用。SEM 显示 CS/ALG 微球呈球形,表面光滑,粒径为 50-100μm。合成的 CS/ALG 微球对与公共卫生相关的细菌具有抗菌和抗生物膜活性。CS/ALG 微球在 5-20μg 的浓度下表现出抗菌活性,对多种抗生素耐药病原体(包括革兰氏阳性金黄色葡萄球菌、粪肠球菌和革兰氏阴性铜绿假单胞菌和普通变形杆菌)具有显著的抑菌圈。此外,原位光显微镜和共聚焦激光扫描显微镜(CLSM)显示,CS/ALG 微球在单次处理 40μg 后抑制了金黄色葡萄球菌、粪肠球菌、铜绿假单胞菌和普通变形杆菌的细菌生物膜形成。总体而言,我们的研究结果强调了化学合成的 CS/ALG 生物材料对多种与人类健康相关的微生物病原体具有高抗菌和抗生物膜活性,因此这种合成途径可以在当前的生物医学科学中进一步用于药物开发。
Mater Sci Eng C Mater Biol Appl. 2013-12-5
Int J Biol Macromol. 2021-8-31
Mater Sci Eng C Mater Biol Appl. 2014-1-1
Artif Cells Nanomed Biotechnol. 2017-8-23
Drug Des Devel Ther. 2025-1-25
ACS Appl Bio Mater. 2024-7-15
Pharmaceuticals (Basel). 2024-4-23
Polymers (Basel). 2021-10-15